Compare Bigfoot Biomedical vs Medtronic MiniMed
Customers evaluate the quality of Bigfoot Biomedical's products using the following success metrics.
Bigfoot Biomedical is 10 yrs old and is based in United States.
Bigfoot Biomedical provides people with insulin-requiring diabetes through the application of smart technology. Its approach includes delivering an Internet-of-Things (IoT) medical device and a cloud-connected system bundled as a monthly subscription service. Bigfoot Biomedical was formerly known as SmartLoop Labs. It was founded in 2014 and is based in Milpitas, California. In September 2023, Bigfoot Biomedical was acquired by Abbott. The terms of the transaction were not disclosed.
Medtronic MiniMed is 39 yrs old and is based in United States.
Medtronic MiniMed is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health. On May 30, 2001, MiniMed was acquired by Medtronic.1B.
Why Bigfoot Biomedical beats Medtronic MiniMed
Information not available because Medtronic MiniMed has not claimed their profile.
Work for Medtronic MiniMed? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Medtronic MiniMed?
Claim your profile now.
- Improved Clinical Outcomes
- Improved Patient Experience
- Better view into patient's data with regard to diabetes management
Bigfoot Unity System
On demand dose decision Support system for patients with type1 or type2 diabetes who take multiple daily injections of insulin
Bigfoot Biomedical works with 2 known companies.
Dr Craig Perlman, Grunberger Diabetes Institute
Why They Buy
News & Analysis
Bigfoot Biomedical has been mentioned in our research 1 time.
Medtronic MiniMed has not been mentioned in our research.
Digital Health 150
The winners of the second annual CB Insights Digital Health 150.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.